These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 19517247)

  • 1. Efficacy and safety of memantine in Lewy body dementia.
    Levin OS; Batukaeva LA; Smolentseva IG; Amosova NA
    Neurosci Behav Physiol; 2009 Jul; 39(6):597-604. PubMed ID: 19517247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Efficacy and safety of memantine in dementia with Lewy bodies].
    Levin OS; Batukaeva LA; Smolentseva IG; Amosova NA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(5):39-46. PubMed ID: 18577956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of cholinesterase inhibitors and memantine in cognitive impairment in Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies: systematic review with meta-analysis and trial sequential analysis.
    Wang HF; Yu JT; Tang SW; Jiang T; Tan CC; Meng XF; Wang C; Tan MS; Tan L
    J Neurol Neurosurg Psychiatry; 2015 Feb; 86(2):135-43. PubMed ID: 24828899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Memantine improves attention and episodic memory in Parkinson's disease dementia and dementia with Lewy bodies.
    Wesnes KA; Aarsland D; Ballard C; Londos E
    Int J Geriatr Psychiatry; 2015 Jan; 30(1):46-54. PubMed ID: 24737460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial.
    Aarsland D; Ballard C; Walker Z; Bostrom F; Alves G; Kossakowski K; Leroi I; Pozo-Rodriguez F; Minthon L; Londos E
    Lancet Neurol; 2009 Jul; 8(7):613-8. PubMed ID: 19520613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of memantine (akatinol) for the correction of cognitive impairments in Parkinson's disease complicated by dementia.
    Litvinenko IV; Odinak MM; Mogil'naya VI; Perstnev SV
    Neurosci Behav Physiol; 2010 Feb; 40(2):149-55. PubMed ID: 20033305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality of life and the effect of memantine in dementia with lewy bodies and Parkinson's disease dementia.
    Larsson V; Engedal K; Aarsland D; Wattmo C; Minthon L; Londos E
    Dement Geriatr Cogn Disord; 2011; 32(4):227-34. PubMed ID: 22122992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of memantine on a patient having preclinical dementia with Lewy bodies.
    Takaya M; Matsusaka K; Yanagida M; Kimura R; Matsunaga H
    Gen Hosp Psychiatry; 2013; 35(3):327.e1-327.e3. PubMed ID: 22840564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Memantine for patients with Parkinson's disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial.
    Emre M; Tsolaki M; Bonuccelli U; Destée A; Tolosa E; Kutzelnigg A; Ceballos-Baumann A; Zdravkovic S; Bladström A; Jones R;
    Lancet Neurol; 2010 Oct; 9(10):969-77. PubMed ID: 20729148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Memantine-induced decompensation in a patient with lewy body dementia.
    Alisky JM
    Ann Acad Med Singap; 2007 Aug; 36(8):707. PubMed ID: 17767347
    [No Abstract]   [Full Text] [Related]  

  • 11. Dementia with lewy bodies: therapeutic opportunities and pitfalls.
    Henriksen AL; St Dennis C; Setter SM; Tran JT
    Consult Pharm; 2006 Jul; 21(7):563-75. PubMed ID: 16934009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Memantine (akatinol) therapy of cognitive impairment in Parkinson's disease complicated by dementia].
    Litvinenko IV; Odinak MM; Mogil'naia VI; Perstenev SV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(10):37-42. PubMed ID: 19008850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment effect of memantine on survival in dementia with Lewy bodies and Parkinson's disease with dementia: a prospective study.
    Stubendorff K; Larsson V; Ballard C; Minthon L; Aarsland D; Londos E
    BMJ Open; 2014 Jul; 4(7):e005158. PubMed ID: 24993765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Memantine for Lewy body disorders: systematic review and meta-analysis.
    Matsunaga S; Kishi T; Iwata N
    Am J Geriatr Psychiatry; 2015 Apr; 23(4):373-383. PubMed ID: 24406251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delusions and hallucinations in dementia with Lewy bodies: worsening with memantine.
    Ridha BH; Josephs KA; Rossor MN
    Neurology; 2005 Aug; 65(3):481-2. PubMed ID: 16087923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The addition of memantine to galantamine increases treatment efficacy in patients with moderate dementia with Lewy bodies].
    Vasenina EE; Gankina OA; Levin OS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(6. Vyp. 2):32-36. PubMed ID: 30346431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Efficacy of memantine in Parkinson's disease with dementia].
    Levin OS; Batukaeva LA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(12):16-23. PubMed ID: 19156121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of memantine in dementia with Lewy bodies.
    Sabbagh MN; Hake AM; Ahmed S; Farlow MR
    J Alzheimers Dis; 2005 Aug; 7(4):285-9. PubMed ID: 16131729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Early use of memantine in the treatment of Lewy body dementia].
    Vanhaute H; Persoons P
    Tijdschr Psychiatr; 2016; 58(11):814-817. PubMed ID: 27868177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Akatinol memantine in the therapy of cognitive disorders in Parkinson's disease].
    Puzin MN; Krivonos OV; Kozhevnikova ZhV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(1):26-9. PubMed ID: 17310793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.